Biologics With increasing incidence of bone and joint diseases and injuries, Regenerative Medicine Market is predicted to reach US $6.5B by 2019 byJosh SandbergJanuary 16, 2017
Biologics Extremities Histogenics Corporation and Collagen Solutions plc Establish Supply Agreement byJosh SandbergSeptember 16, 2015
Biologics Recon MiMedx To Present At 35th Annual Canaccord|Genuity Growth Conference byJosh SandbergAugust 4, 2015
Hospitals Recon Tissue Regenix Group plc: First Coast Service Options Inc. Approves Medicare Coverage for DermaPure byJosh SandbergJuly 31, 2015
Recon Histogenics Corporation Announces Dr. Gloria Matthews as Chief Medical Officer byJosh SandbergJuly 15, 2015
